Mahesh Nanjundappa

Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis

Kévin Pethe, Pablo Bifani, Jichan Jang et al. · Nature Medicine · 2013 · 595 citations · Full text

Medicinal Chemistry, Potent Clinical Candidate, Pulmonary Tuberculosis +7

A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy

Kévin Pethe, Patrícia Carvalho de Sequeira, Sanjay Agarwalla et al. · Nature Communications · 2010 · 303 citations · Full text

Bioorganic Chemistry, Tuberculosis Prevention, Bacteriology +24

Indolcarboxamide Is a Preclinical Candidate for Treating Multidrug-Resistant Tuberculosis

Srinivasa P. S. Rao, Suresh B. Lakshminarayana, Ravinder Reddy Kondreddi et al. · Science Translational Medicine · 2013 · 149 citations

Tuberculosis Prevention, Pharmacotherapy, Antimicrobial Chemotherapy +18

Peptide Deformylase Inhibitors as Potent Antimycobacterial Agents

Jeanette Teo, Pamela Thayalan, David Beer et al. · Antimicrobial Agents and Chemotherapy · 2006 · 56 citations · Full text

Antimicrobial Drug Discovery, Biochemistry, M. Tuberculosis +15

Peptide deformylase inhibitors of Mycobacterium tuberculosis: Synthesis, structural investigations, and biological results

A. Pichota, Jeyaraj Duraiswamy, Zheng Yin et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 47 citations · Full text

Pulmonary Tuberculosis, Biochemistry, Natural Sciences +8